CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,432,082
- in 7 filings
Net −$19,432,082. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-12 | HARROW HEALTH, INC. 10% owner | Sale | −1,518,000 | $7.00 | $10.6M | 1,982,000 |
| 2020-10-16 | Opaleye Management Inc. 10% owner | Purchase | +385,000 | $7.00 | $2.7M | 3,885,000 |
| 2020-10-16 | Opaleye Management Inc. 10% owner | Purchase | +15,000 | $7.00 | $105K | 155,000 |
| 2020-03-12 | BAUM MARK L Director | Grant or award · Stock Option (Right to buy) | +27,400 | 27,400 | ||
| 2020-03-12 | Troutman William Wilson CFO, Treasurer & Secretary | Grant or award · Stock Option (Right to buy) | +186,200 | 186,200 | ||
| 2020-03-12 | CASAMENTO CHARLES J Director | Grant or award · Stock Option (Right to buy) | +27,400 | 27,400 | ||
| 2020-03-12 | MAIER PAUL V Director | Grant or award · Stock Option (Right to buy) | +27,400 | 27,400 | ||
| 2020-03-12 | RIEDEL NORBERT G Director | Grant or award · Stock Option (Right to buy) | +27,400 | 27,400 | ||
| 2020-03-12 | BRYNJELSEN SEAN President & CEO | Grant or award · Stock Option (Right to buy) | +490,000 | 490,000 | ||
| 2019-08-13 | BRYNJELSEN SEAN President & CEO | Purchase | +5,000 | $6.15 | $31K | 1,025,000 |
| 2019-08-09 | CASAMENTO CHARLES J Director | Purchase | +3,500 | $6.11 | $21K | 71,920 |
| 2019-05-21 | BRYNJELSEN SEAN President & CEO | Purchase | +8,600 | $7.96 | $68K | 1,020,000 |
| 2019-05-20 | BRYNJELSEN SEAN President & CEO | Purchase | +1,400 | $7.78 | $11K | 1,011,400 |
| 2019-02-20 | RIEDEL NORBERT G Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2019-02-20 | MAIER PAUL V Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2019-02-20 | CASAMENTO CHARLES J Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2019-02-20 | BAUM MARK L Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2019-02-20 | Troutman William Wilson CFO, Treasurer & Secretary | Grant or award · Stock option (right to buy) | +95,000 | 95,000 | ||
| 2019-02-20 | BRYNJELSEN SEAN President & CEO | Grant or award · Stock option (right to buy) | +250,000 | 250,000 | ||
| 2018-11-15 | CASAMENTO CHARLES J Director | Conversion | +8,675 | 63,420 |
Page 12 of 13 · 249 trades